Research and Innovation
Liverpool School of Tropical Medicine has led pioneering research into infectious and neglected diseases since 1898. Through life-changing science and education, we aim to improve health equity and strengthen responses in under-resourced communities.
Research profile
LSTM is a global leader in infection, tropical medicine and global health research. We lead translational research across the full pathway, from early discovery and laboratory science through to clinical trials, public health implementation and global policy change.
Our end-to-end approach ensures scientific breakthroughs are translated into real-world impact, improving health outcomes where they’re needed most.
Find out more about our research by exploring the themes that guide our work
- Malaria and Neglected Tropical Diseases (NTDs)
- Community Health and Resilient Health Systems
- Emerging and Re-emerging Diseases
- Equity and Capacity Research
- Innovation to Impact: Therapeutics, Diagnostics, Vaccines
- Maternal, Neonatal, Sexual and Reproductive Health
- Tuberculosis and Anti-microbial Resistance
- Vector Control and Resistance Management
- Climate Health
Centres of Excellence
Our Centres, Units and Institutes bring together leading experts across disciplines to tackle complex global health challenges. These specialist groups drive collaborative, impact-focused research, advancing discovery, shaping policy and strengthening health systems in partnership with communities worldwide.
Discover all of our Centres, Units and Institutes
Our research is focused around four major global health challenges that shape the wellbeing of people and communities worldwide.
Highighted projects
Tiny Targets
Tiny Targets is an innovative vector control initiative led by LSTM and partners to reduce the spread of sleeping sickness. The aim was to reduce tsetse fly densities below the threshold that allows transmission of the disease.
Anti-Wolbachia Consortium (A·WOL)
The Anti-Wolbachia Consortium (A·WOL), led by LSTM, is pioneering a novel approach to treating filarial diseases by targeting Wolbachia, an essential bacterial symbiont within the worms that cause onchocerciasis and mosquitoes that cause lymphatic filariasis.
Hybridisation in UroGenital Schistosomiasis (HUGS)
The Hybridisation in UroGenital Schistosomiasis (HUGS) project is an international research collaboration focused on understanding the impact of parasite hybridisation on disease control.
Research culture
The world’s biggest health challenges need the world’s most diverse minds working together. At LSTM, we believe that inclusive, supportive, and collaborative research communities are key to delivering world-leading research and breakthroughs that transform global health.
Research culture
Discover our research through video
Introduction to the Centre for Snakebite Research and Interventions (CSRI)
13 January 2025
2:01
Inside LITE’s Insectary: Rearing Mosquitoes for Insecticide Testing
12 September 2025
1:51